Current state and future directions for veterinary antimicrobial resistance research

Author:

Maddock Kelli J.1,Bowden Robert2,Cole Stephen D.3,Diaz-Campos Dubraska4,Daniels Joshua B.5,LeCuyer Tessa E.6,Li Xian-Zhi7,Loy John Dustin8,Sanchez Susan9,Stenger Brianna L. S.1,Burbick Claire R.10

Affiliation:

1. Veterinary Diagnostic Laboratory, North Dakota State University, Fargo, ND

2. Beth Israel Deaconess Medical Center, Boston, MA

3. School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA

4. College of Veterinary Medicine, The Ohio State University, Columbus, OH

5. Veterinary Diagnostic Laboratory, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO

6. Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California-Davis, Davis, CA

7. Veterinary Drugs Directorate, Health Canada, Ottawa, ON, Canada

8. Nebraska Veterinary Diagnostic Center, School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE

9. Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA

10. Washington Animal Disease Diagnostic Laboratory, Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, WA

Abstract

Abstract Antimicrobial resistance (AMR) is a critical One Health concern with implications for human, animal, plant, and environmental health. Antimicrobial susceptibility testing (AST), antimicrobial resistance testing (ART), and surveillance practices must be harmonized across One Health sectors to ensure consistent detection and reporting practices. Veterinary diagnostic laboratory stewardship, clinical outcomes studies, and training for current and future generations of veterinarians and laboratorians are necessary to minimize the spread of AMR and move veterinary medicine forward into an age of better antimicrobial use practices. The purpose of this article is to describe current knowledge gaps present in the literature surrounding ART, AST, and clinical or surveillance applications of these methods and to suggest areas where AMR research can fill these knowledge gaps. The related Currents in One Health by Maddock et al, JAVMA, March 2024, addresses current limitations to the use of genotypic ART methods in clinical veterinary practice.

Publisher

American Veterinary Medical Association (AVMA)

Reference55 articles.

1. Antimicrobial use and resistance in plant agriculture: a One Health perspective;Miller SA,2022

2. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis,2022

3. National action plan for combating antibiotic–resistant bacteria 2020–2025. Federal Task Force on Combating Antimicrobial Resistant Bacteria. Accessed December 20 2023. https://www.hhs.gov/sites/default/files/carb-national-action-plan-2020-2025.pdf

4. Policy pathways to combat the global crisis of antimicrobial resistance. Accessed December 20, 2023. American Society for Microbiology. https://asm.org/getmedia/5f665383-881a-493d-ae05-04a960a25548/AMR-Policy-Paper-2023.pdf

5. One Health approach for reporting veterinary carbapenem-resistant Enterobacterales and other bacteria of public health concern;KuKanich K,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3